Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.
Barsotti GC, Luciano R, Kumar A, Meliambro K, Kakade V, Tokita J, Naik A, Fu J, Peck E, Pell J, Reghuvaran A, Tanvir EM, Patel P, Zhang W, Li F, Moeckel G, Perincheri S, Cantley L, Moledina DG, Wilson FP, He JC, Menon MC.
Barsotti GC, et al. Among authors: menon mc.
Kidney Int Rep. 2024 Feb 13;9(5):1354-1368. doi: 10.1016/j.ekir.2024.02.006. eCollection 2024 May.
Kidney Int Rep. 2024.
PMID: 38707807
Free PMC article.